ACTA1 - C-terminal region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-ACTA1 - C-terminal region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | ACTA1 - C-terminal region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | cow, dog, guinea pig, horse, human, mouse, rabbit, rat, yeast, zebrafish |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This is a rabbit polyclonal antibody against ACTA1. It was validated on Western BlotTarget Description: The product encoded by this gene belongs to the actin family of proteins, which are highly conserved proteins that play a role in cell motility, structure and integrity. Alpha, beta and gamma actin isoforms have been identified, with alpha actins being a major constituent of the contractile apparatus, while beta and gamma actins are involved in the regulation of cell motility. This actin is an alpha actin that is found in skeletal muscle. Mutations in this gene cause nemaline myopathy type 3, congenital myopathy with excess of thin myofilaments, congenital myopathy with cores, and congenital myopathy with fiber-type disproportion, |
| Immunogen | n/a |
| Other Names | [actin, alpha skeletal muscle; Actin, alpha skeletal muscle; actin, alpha skeletal muscle; actin alpha 1, skeletal muscle; Alpha-actin-1] |
| Gene, Accession # | [ACTA1], Gene ID: 58, NCBI: NP_001091, UniProt: P68133 |
| Catalog # | MBS3215030 |
| Price | $335 |
| Order / More Info | ACTA1 - C-terminal region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies